Project Details
Abstract
This is a four years project. The object of this project is to use cultured
human hepatoma cell line and HBV transgenic mice as two screening models to
screen anti-HBV activity in different synthetic compounds and nature product
preparations. Results generated from this study will identify novel drug leads for
developing anti-HBV drug in the future.
Hepatocellular carcinoma (HCC) is the leading cause of cancer death
among male Chinese. The mortality of HCC patients is nearly 100%. Infection of
HBV frequently results in acute and chronic hepatitis and is associated with a high
risk of developing liver cancer in human. New infection with HBV can be
prevented by vaccination. However, there are still four millions HBV chronic
carriers in Taiwan waiting for drug to stop disease progression and to develop new
anti-HBV therapeutics is still urgently needed.
We have studied anti-HBV activity from natural products in human
hepatoma cells for years. One of the pure compounds isolated from Taiwania
cryptomerioides Hayata , HE145, has shown to have potent anti-HBV activity.
HE145 suppresses endogenous HBsAg production in Hep3B cells, inhibits the
replication of HBV in cultured human hepatoma HepG2 cells. The antiviral
application of HE145 has granted patent from both US and European Union. In this
project, we will employ cultured human hepatoma cells and HBV transgenic mice
as models to screen the bioactive natural products supplied from other chemistry
laboratories in this national program project. This study will not only get bioactive
compounds through bioacssay- leaded screeninng but also validate its potential as
anti-HBV drug in our HBV transgenic mice model.
The novel bioactive compounds with diverse biological activities from
natural products give us a unique opportunity to develop research area of chemical
biology in Taiwan. Fully integration of chemistry, biology will strengthen each PI’s
specialty and synergistically enhance our scientific competitiveness. This project
will set an example of teamwork effort to attack the major health threaten in
Taiwan.
Project IDs
Project ID:PD9408-0205
External Project ID:NSC94-2323-B182-001
External Project ID:NSC94-2323-B182-001
| Status | Finished |
|---|---|
| Effective start/end date | 01/08/05 → 31/07/06 |
Keywords
- screening anti-viral drug
- human hepatoma cells
- HBV transgenic mice
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.